Denise Esposito is a partner in the law firm of Covington & Burling LLP, where she serves as a co-chair of the Life Sciences Industry Group and previous co-chair of the Food Drug and Device Practice Group. Denise has more than 30 years of experience in the life sciences industry, including in senior leadership roles within the U.S. Food and Drug Administration (FDA), as the General Counsel of a publicly traded biopharmaceutical company, and as a partner in private practice. While at FDA, Professor Esposito served as Chief of Staff to the FDA Commissioner, Deputy General Counsel for Drugs and Biologics, and Director of the Office of Regulatory Policy in the Center for Drug Evaluation and Research. In her practice at Covington, she regularly advises pharmaceutical, biotechnology, and medical device clients on a wide range of FDA-facing matters, including product review and approval, emergency use authorization, risk management, the advertising and promotion of medical products, and numerous other topics. She works with clients on FDA engagement strategies, formal and informal FDA dispute resolution, FDA administrative hearings and public meetings, and crisis management around FDA actions. Professor Esposito is a graduate of the University of Michigan Law School, where she was a member of the Michigan Law Review and was elected to the Order of the Coif. She earned her Bachelor of Arts in Economics from Rutgers University.